Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, reported that Power3 has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc.